Please provide your email address to receive an email when new articles are posted on . Etherna is a technology platform company devoted to mRNA construction and optimization. Etherna will receive an ...

Bayer has filed patent infringement lawsuits against COVID-19 vaccine makers Pfizer, BioNTech, Moderna, and Johnson & Johnson ...

The rapid advancements in mRNA-based therapeutics have ushered in a new era of medicine, promising revolutionary treatments for a wide range of diseases. However, despite the tremendous potential, ...

The SARS-CoV-2 pandemic greatly accelerated the development of messenger RNA technology by demonstrating the safety, effectiveness and scalability of mRNA-based vaccines 1. Writing in Nature, Zhang et ...

Two COVID-19 mRNA vaccines, made by BioNTech/Pfizer and Moderna, are helping to change the course of the COVID-19 pandemic. A third mRNA vaccine, developed by CureVac and known as CVnCoV, has not had ...

Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want to ban them and the government is cutting funding. By Kate Zernike To ...

Clinical evaluation of messenger RNA involves vaccination of tens of thousands of participants requiring the production of a sufficient quantity of mRNA drug substance. Manufacturing and testing ...

Sensible Biotechnologies Slashes Time Taken to Optimize Novel Cell-Based mRNA Therapeutics by More Than 90% with AI Platform Built on NVIDIA Technology Sensible Biotechnologies, a biotechnology ...

— Partnership Combines Sequence Design Expertise with End-to-End GMP Manufacturing to Streamline mRNA Development and Scale-up — BIOVECTRA, a part of Agilent Technologies Inc., and Revolution ...

The United States may be losing its edge in mRNA technology­­. The technology, which powered life-saving COVID-19 vaccines and is now rocketing new cancer therapeutics forward, will soon undergo a ...

BIOVECTRA, a part of Agilent Technologies Inc., and Revolution Biomanufacturing Inc. announced a collaboration that grants BIOVECTRA access to Revolution Biomanufacturing's proprietary platforms for ...